In our studies, high PLK1 level was also associated with clinical features such as grade, IDH mutation status, 1p/19q co-deleted status, and methylation status of MGMT promoter in glioma (Supplementary Figure 2). This evidence concerns the gene MGMT and central nervous system cancer.